Logo

High Throughput Genomics Sells Omix Imager to Celgene

Aug 19, 2002

NEW YORK, Aug. 19 - High Throughput Genomics today said it has sold Celgene one of its Omix Imager target- and drug-discovery platforms and ArrayPlate kits.

 

Terms of the deal also call for HTG to develop and supply genomic-profiling kits to be used in chemicogenomics and pharmacogenomics studies, HTG said.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.